Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "operations"

932 News Found

Lupin enters into BTA with Lupin Manufacturing Solutions
News | October 17, 2023

Lupin enters into BTA with Lupin Manufacturing Solutions

Lupin enters into BTA with Lupin Manufacturing Solutions


Zydus appoints Punit Patel as President and CEO, Americas
People | October 16, 2023

Zydus appoints Punit Patel as President and CEO, Americas

Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace


Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
News | October 16, 2023

Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines

Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug


Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
News | October 16, 2023

Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities

The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions


Emmes acquires VaxTRIALS
News | October 07, 2023

Emmes acquires VaxTRIALS

VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth


Cipla launches drone delivery of critical medicines in Himachal Pradesh
Supply Chain | September 27, 2023

Cipla launches drone delivery of critical medicines in Himachal Pradesh

Commenced operations in flood-affected Himachal Pradesh


Briefs: Mankind Pharma and Sequent Scientific
News | September 26, 2023

Briefs: Mankind Pharma and Sequent Scientific

Mankind Pharma commences the commercial operations newly set-up plant in Udaipur


Emmes appoints Peter Ronco as CEO
People | September 23, 2023

Emmes appoints Peter Ronco as CEO

Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri


Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
News | September 21, 2023

Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia

With this, the company has secured 511 marketing approvals for its oncology products across 66 countries


Jupiter Life Line Hospitals lists at 32.38% premium
News | September 20, 2023

Jupiter Life Line Hospitals lists at 32.38% premium

The market capitalization of the company stood at Rs. 7,000 crore +